Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of November 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on November 12, 2019. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 and includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text contains only cover page and signature information. It does not include specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this excerpt.
Material Changes
The filing text does not provide comparative financial data or narrative descriptions of material changes versus prior periods.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, contingencies, and unusual items are not detailed in the provided text. The filing references a press release (Exhibit 99.1) which may contain such information, but the content of that exhibit is not included in the input.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Press Release) for specific operational updates or financial announcements.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed on the filing.
- Review the full Form 20-F annual report for comprehensive financial statements and risk disclosures.